Lavin Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.03 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -18.20%
- Profit Growth 106.62%
- Ebitda 108.94%
- Net Worth 0.16%
- Total Assets -13.89%
About Lavin Laboratories
Lavin Laboratories Private Limited (LLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 15 July 2020 (Four years and seven months 7 days old ). Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.03 M, as per Ministry of Corporate Affairs (MCA) records.
Putchakayala Tejareddy, Jonnala Reddy, Donthireddy Brahmareddy, and One other member serve as directors at the Company.
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290AP2020PTC114970
- Company No.
114970
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Lavin Laboratories?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Putchakayala Tejareddy  | Director | 15-Jul-2020 | Current |
| Jonnala Reddy | Director | 15-Jul-2020 | Current |
| Donthireddy Brahmareddy | Director | 15-Jul-2020 | Current |
| Giriprasad Malavattu | Director | 30-Aug-2022 | Current |
Financial Performance of Lavin Laboratories.
Lavin Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 18.2% decrease. The company also saw a substantial improvement in profitability, with a 106.62% increase in profit. The company's net worth moved up by a moderate rise of 0.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lavin Laboratories?
Unlock access to Lavin Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lavin Laboratories?
Lavin Laboratories has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lavin Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lavin Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.